Join the Epinephrine group to help and get support from people like you.
Epinephrine News
Related terms: Epinephrine Topical, Epinephrine Ophthalmic
Many Kids Unnecessarily Hospitalized Following Allergic Reactions
FRIDAY, June 27, 2025 — Many kids are spending a lot of unnecessary time under observation in a hospital following a sudden allergic emergency, a new study concludes. About 17% of kids are admitted f...
ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic Reactions in Pediatric Patients
SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) – ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...
FDA Medwatch Alert: FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA
January 16, 2025 – FDA is warning health care professionals not to use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC, in Largo, Fla., and Endo USA, in Malvern, Pa. Health care ...
FDA Medwatch Alert: Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors
MALVERN, PA, December 20, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adren...
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
FRIDAY, Oct. 25, 2024 – Many anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at...
Epinephrine: Tips to the 'EpiPen' Ingredient and How It Treats Anaphylaxis
TUESDAY, Oct. 8, 2024 --- The recent approval of a new epinephrine nasal spray, Neffy, gives patients a powerful new way to keep life-threatening allergic reactions at bay. But that doesn't mean...
Monthly News Roundup - August 2024
FDA Clears Pfizer and Moderna 2024-2025 COVID-19 mRNA Vaccines On August 22, the FDA approved the latest COVID-19 mRNA monovalent vaccines from Moderna (Spikevax) and Pfizer / BioNTech (Comirnaty) ...
FDA Approves neffy (epinephrine nasal spray) Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) – ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients...
FDA Medwatch Alert: Spectrum Laboratory Products, Inc. Issues Voluntary Worldwide Recall of Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient (API) Due to Discoloration of Product
January 9, 2023 – Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API) used to manufacture or...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals of Amneal and Impax Laboratories Epinephrine Auto-Injector Device Malfunctions
June 1, 2020 – FDA is alerting patients, caregivers and health care professionals to immediately inspect certain lots of Amneal and Impax epinephrine auto-injector 0.3 mg to ensure the yellow “stop c...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ lower...
FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Richmond, VA (November 20, 2017) kaléo, a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application ...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEP...
FDA Medwatch Alert: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device
ISSUE: Mylan N.V. announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (...
Further information
Related condition support groups
Anaphylaxis, Allergic Reactions, Asthma - Acute, Allergies, Shock